IntellicapIntellicap
HomeTrackerWatchlist
/
IntellicapIntellicap

Professional-grade intellectual capital analysis for Indian equity markets. Making smarter investing accessible.

Intellectual Capital

  • What is IC?
  • IC Reporting
  • Investing Insights
  • IC News

Tools

  • icTracker
  • icTopTen
  • icFunding
  • icValue

Services

  • icAdvisor India
  • icAdvisor USA
  • MF Advisor
  • Financial Planner

Company

  • About Us
  • Contact Us
  • Investor Charter
  • Terms of Use

Copyright © 2007-2026 Intellicap - All rights reserved.

Made in India. SEBI registered investment advisor. Investment in securities market are subject to market risks.

HomeCompaniesAarti Drugs

Aarti Drugs

Pharma DrugsBSE: 524348NSE: AARTIDRUGS
ISININE767A01016
FreeFloat33.95%
FnONo
Lot Size0

Indices containing this Stock

Valuation

Rs. Cr

Market Cap is 1.83x Intrinsic Worth -- this stock appears overvalued based on IC methodology

Intellectual Capital (IC)

547.81

Rs. Cr

Net Worth (NW)

1,509.14

Rs. Cr

Intrinsic Worth (IW)

IC Ratios

3 Favorable, 2 Unfavorable -- 3 of 5 IC ratios are favorable -- moderate intellectual capital health

Knowledge Basis (IC/IW)

26.63%

IC Gross Margin (EBITDA/IC)

51.25%

IC Net Margin (NPT/IC)

Stock Price

Intrinsic ValueRs. 225.37As of 2025-12-31
Premium+58.7%
Market PriceRs. 357.65
2026-04-09-3.9 (-1.09%)

Stock Sentimeter

Sentimeter is based on market data calculations and is NOT investment advice

Based on 0/3 positive fundamental signals and a Bearish technical outlook, this stock shows caution warranted based on current signals.

Fundamental - Quality

  • EVA > 0No
  • KB > 50%No
  • 0 < M2IV < 1No

Technical - Daily Price Action

  • 10 DMA345.71
  • 50 DMA360.97

Analysis Charts

Is this stock undervalued?

Intrinsic Value vs Book Value vs Market Price over Time

Does this business have significant knowledge assets?

Knowledge Basis over Time

Is this business generating enough profits?

Economic Value Added over Time

Quarterly Results

Rs. Cr | * C - Consolidated, S - Standalone

QoQ Trend:
Sales↓7.8%
PAT↓10.2%
EBITDA↓33.3%
QuarterType*SalesIncomeEBITDAEBITPBTPATNPT
Mar-23C7427439482735656

Latest News

  1. Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
  2. Past performance, by way of backtesting or by way of actuals, is no guarantee of future returns.
  3. Data mentioned on this page is for educational purpose only and does not constitute investment advice.

Standard Warning - Investment in securities markets are subject to market risk. Read all the related documents carefully before investing.

2,056.96

Rs. Cr

Market Cap (MC)

3,757.13

Rs. Cr

Economic Value Added

-32.23

Rs. Cr

32.66%

Knowledge Turnover (Sales/IC)

4.29

Market to IV (MC/IW)

1.83

  • Vol-Price trendFalling

    • Near-term Outlook

    Bearish
    Jun-23C6616628572644848
    Sep-23C6426427765564040
    Dec-23C6066087259523737
    Mar-24C6206218773644747
    Jun-24C5555566653443333
    Sep-24C5986006955463535
    Dec-24C5575697460513737
    Mar-25C6776799580716363
    Jun-25C5915917460515454
    Sep-25C6536538468604545
    Dec-25C6026035638294141